katre klow What's new in women's golf fashion? Interview: Kate Clow, founder of

Site-specific inactivation of aldose reductase by 4-hydroxynonenal

This ensures smooth adoption of liposomal formulations into your research projects and maximizes the likelihood of successful experimental outcomes

doi: 10.1038/nrc.2015.2 102 SabnisAJBivonaTG

Direct fusion of drugs to recombinant human serum albumin (HSA), however, offers the opportunity to control and fine-tune the half-life of fusion constructs through engineered FcRn binding affinities

Understanding the risks and side effects will create confidence in the patient when they undergo IV iron therapy and will help them be well-equipped to deal with its adverse reactions, if any